ClinicalTrials.Veeva

Find clinical trials for Glioblastoma (GBM) in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Glioma
Brain Cancer
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Taipei City, TWN:

Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients

parallel group to evaluate the efficacy and safety of autologous dendritic cell vaccination (ADCV01) as an add-on treatment for primary glioblastoma...

Enrolling
GBM
Biological: autologous dendritic cells

Phase 2

Ever Supreme Bio Technology

Taoyuan, Non-US, Taiwan and 2 other locations

with newly diagnosed glioblastoma....

Enrolling
Malignant Neoplasm
Malignant Neoplasm of Brain
Radiation: Standard radiotherapy
Drug: Temozolomide

Phase 1, Phase 2

Novelwise Pharmaceutical Corporation

Taoyuan City, Taiwan and 4 other locations

of this trial is to evaluate the effect of add-on JP001 to standard chemoradiation in increasing overall survival (OS) on newly diagnosed glioblastoma...

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: CCRT

Phase 2, Phase 3

Johnpro Biotech

Taipei City, Taiwan and 1 other location

Assess safety and tolerability of ADI-PEG 20 in combination with radiotherapy and Temozolomide in newly diagnosed GBM...

Enrolling
Glioblastoma Multiforme (GBM)
Drug: Temozolomide
Drug: ADI-PEG20

Phase 1

Polaris Group

Taoyuan, Taiwan

(TNBC), ovarian cancer, gastric cancer, colorectal cancer (CRC), glioblastoma (GBM), biliary tract cancers (BTC), or pancreatic can...

Active, not recruiting
Glioblastoma
Gastric Cancer
Biological: Pembrolizumab
Drug: Lenvatinib

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Taipei, Taiwan and 87 other locations

Researchers are looking for a better way to treat people with solid tumors. Before a treatment can be approved for people to take, researchers do cli...

Active, not recruiting
Solid Tumors
Drug: Regorafenib, (Stivarga, BAY73-4506)
Drug: Nivolumab (Opdivo)

Phase 2

Bayer
Bayer

Taipei, Taiwan and 33 other locations

To assess:efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification,...

Enrolling
Glioblastoma Multiforme
Brain Tumor
Drug: APL-101 Oral Capsules

Phase 2

Apollomics

Taipei City, Taiwan and 90 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems